Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Stiebel-Kalish H et al. - Current evidence demonstrates the efficacy of intravenous corticosteroids in decreasing CAS in patients with moderate-to-severe GO. Intravenous pulse corticosteroids therapy has a small but statistically significant advantage oral therapy, and causes significantly less adverse events. Somatostatin analogs have marginal clinical efficacy. The efficacy of orbital radiotherapy as single therapy remains unclear, while the combination of radiotherapy with corticosteroids has better efficacy than either radiotherapy or oral costicosteroids alone.

Today in Pharmacology/kinetics...keeping you current

Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Pituitary, 12/08/09

Pioglitazone and mechanisms of CV protection
QJM: An International Journal of Medicine, 12/08/09

Rosiglitazone was non-inferior to metformin plus sulphonylurea for CV events but increased risk of HF and fractures in type 2 diabetes
Evidence-Based Medicine, 12/07/09

Today in Thyroid/Parathyroid...keeping you current

Controversies in Thyroid Pathology: Thyroid Capsule Invasion and Extrathyroidal Extension
Annals of Surgical Oncology, 12/08/09

No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
European Journal of Nuclear Medicine & Molecular Imaging, 12/08/09

Parathyroidectomy in the elderly population: Does age really matter
The Laryngoscope, 12/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address